Employees: 11 (2023.0)Legal category: 5485Size: PMECreation date: 2003-05-02 (23 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: NICE (06000), Alpes-Maritimes
SELARL PHARMACIE DE LA MADELEINE : revenue, balance sheet and financial ratios
SELARL PHARMACIE DE LA MADELEINE is a French company
founded 23 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in NICE (06000),
this company of category PME
shows in 2022 a revenue of 5.1 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELARL PHARMACIE DE LA MADELEINE (SIREN 449020916)
Indicator
2025
2024
2023
2022
2021
2020
2019
2018
2017
2017
2016
Revenue
N/C
N/C
N/C
5 061 553 €
4 970 998 €
4 809 288 €
4 514 196 €
4 216 035 €
4 113 295 €
1 397 076 €
4 225 119 €
Net income
215 688 €
118 768 €
156 166 €
186 718 €
254 968 €
279 592 €
255 054 €
286 015 €
140 545 €
74 507 €
161 273 €
EBITDA
N/C
N/C
N/C
282 372 €
351 142 €
355 232 €
365 155 €
414 216 €
246 551 €
111 758 €
366 615 €
Net margin
N/C
N/C
N/C
3.7%
5.1%
5.8%
5.7%
6.8%
3.4%
5.3%
3.8%
Revenue and income statement
In 2025, SELARL PHARMACIE DE LA MADELEINE generates positive net income of 216 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2025: 161 k€ -> 216 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
215 688 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 87%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 46%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
87.11%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
45.975%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution SELARL PHARMACIE DE LA MADELEINE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2017
2018
2019
2020
2021
2022
2023
2024
2025
Debt ratio
103.447
158.339
85.614
73.386
71.437
68.539
63.689
69.068
72.575
112.009
87.11
Financial autonomy
43.187
35.628
47.493
50.938
51.194
51.548
52.578
51.695
49.407
40.401
45.975
Repayment capacity
8.298
45.825
12.273
6.652
7.715
8.354
7.14
10.959
None
None
None
Cash flow / Revenue
5.686%
5.294%
3.506%
6.354%
4.991%
4.266%
4.66%
2.963%
None%
None%
None%
Sector positioning
Debt ratio
87.112025
2023
2024
2025
Q1: 13.7
Med: 49.79
Q3: 129.09
Average+10 pts over 3 years
In 2025, the debt ratio of SELARL PHARMACIE DE LA MA... (87.11) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
45.98%2025
2023
2024
2025
Q1: 33.42%
Med: 53.72%
Q3: 72.08%
Average-11 pts over 3 years
In 2025, the financial autonomy of SELARL PHARMACIE DE LA MA... (46.0%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 104.49. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
104.491
Liquidity indicators evolution SELARL PHARMACIE DE LA MADELEINE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2017
2018
2019
2020
2021
2022
2023
2024
2025
Liquidity ratio
150.569
493.615
140.075
198.318
182.934
178.284
179.777
156.915
137.772
116.546
104.491
Interest coverage
13.447
9.58
14.165
6.185
5.412
1.938
5.022
7.172
None
None
None
Sector positioning
Liquidity ratio
104.492025
2023
2024
2025
Q1: 131.03
Med: 182.25
Q3: 258.64
Watch-6 pts over 3 years
In 2025, the liquidity ratio of SELARL PHARMACIE DE LA MA... (104.49) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2025)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2025)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2025)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2025)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution SELARL PHARMACIE DE LA MADELEINE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2017
2018
2019
2020
2021
2022
2023
2024
2025
Operating WCR
633 557 €
483 011 €
567 511 €
591 721 €
574 386 €
554 030 €
486 412 €
412 061 €
0 €
0 €
0 €
Inventory turnover (days)
48
109
46
44
39
41
36
31
0
0
0
Customer payment term (days)
10
22
9
9
11
7
6
5
0
0
0
Supplier payment term (days)
51
138
49
50
49
49
54
41
0
0
0
Positioning of SELARL PHARMACIE DE LA MADELEINE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of SELARL PHARMACIE DE LA MADELEINE is estimated at
3 426 229 €
(range 2 325 055€ - 5 376 225€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
2325k€3426k€5376k€
3 426 229 €Range: 2 325 055€ - 5 376 225€
NAF 5 année 2025
Valuation method used
Net Income Multiple
215 688 €
×
15.9x
=3 426 230 €
Range: 2 325 056€ - 5 376 226€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELARL PHARMACIE DE LA MADELEINE with other companies in the same sector:
Frequently asked questions about SELARL PHARMACIE DE LA MADELEINE
What is the revenue of SELARL PHARMACIE DE LA MADELEINE ?
The revenue of SELARL PHARMACIE DE LA MADELEINE in 2022 is 5.1 M€.
Is SELARL PHARMACIE DE LA MADELEINE profitable?
Yes, SELARL PHARMACIE DE LA MADELEINE generated a net profit of 216 k€ in 2025.
Where is the headquarters of SELARL PHARMACIE DE LA MADELEINE ?
The headquarters of SELARL PHARMACIE DE LA MADELEINE is located in NICE (06000), in the department Alpes-Maritimes.
Where to find the tax return of SELARL PHARMACIE DE LA MADELEINE ?
The tax return of SELARL PHARMACIE DE LA MADELEINE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELARL PHARMACIE DE LA MADELEINE operate?
SELARL PHARMACIE DE LA MADELEINE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart